Navigation Links
Vermillion, Inc. Announces Receipt of Notice of Noncompliance From Nasdaq
Date:9/7/2007

FREMONT, Calif., Sept. 7 /PRNewswire-FirstCall/ -- Vermillion, Inc. (the "Company") (Nasdaq: VRML) today announced that on September 6, 2007 it received a notice of noncompliance from The Nasdaq Stock Market ("Nasdaq") indicating that the Company fails to comply with the minimum bid price requirement for continued listing set forth in Marketplace Rule 4310(c)(4). The letter gives the Company notice that the bid price of its common stock has closed under $1.00 for the last 30 business days.

Pursuant to Nasdaq Marketplace Rule 4310(c)(8)(D), the Company has been provided an initial period of 180 calendar days, or until March 4, 2008, to regain compliance. The letter states the Nasdaq staff will provide written notification that the Company has achieved compliance with Rule 4310(c)(4) if at any time before March 4, 2008, the bid price of the Company's common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days.

If the Company cannot demonstrate compliance with Rule 4310(c)(4) by March 4, 2008, the Nasdaq staff will determine whether the Company meets The Nasdaq Capital Market initial listing criteria set forth in Nasdaq Marketplace Rule 4310(c), except for the bid price requirement. If the Company meets the initial listing criteria, the Nasdaq staff will notify the Company that it has been granted an additional 180 calendar day compliance period. If the Company is not eligible for an additional compliance period, the Nasdaq staff will provide written notice that the Company's securities will be delisted. At that time, the Company may appeal the Nasdaq staff's determination to delist its securities to a Listing Qualifications Panel.

About Vermillion

Vermillion, Inc. (formerly Ciphergen Biosystems, Inc.) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has ongoing diagnostic programs in oncology/hematology, cardiology and women's health with an initial focus in ovarian cancer. Based in Fremont, California, more information about Vermillion can be found on the Web at http://www.vermillion.com.


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. PowderMed Announces Needle-Less Flu Vaccine
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
9. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... 03, 2016 , ... Sue Desmond-Hellmann, chief executive officer of the Bill & ... of human possibility in her keynote address at Georgia State University’s spring commencement ... on her rich experience as a scientist, physician and executive, Desmond-Hellmann leads the Gates ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... brainsalvation tool – a web application that helps people assess their risk of ... brainsalvation™ web app will provide users a “Risk Reduction Score™” that summarizes how ...
(Date:5/3/2016)... ... , ... Registration is now open for the 31st annual AIDS Walk Boston & 5K ... on the Esplanade. The event regularly draws thousands of participants, making it AIDS Action Committee’s ... fully sanctioned by the USA Track & Field Association. , The AIDS Walk & ...
(Date:5/3/2016)... ... 03, 2016 , ... Sandbox, one of the nation’s leading ... the newly created position of executive vice president, chief creative officer.     , In ... Chicago and LA offices. He reports to Nancy Finigan, president of those offices. ...
(Date:5/3/2016)... ... 03, 2016 , ... BioPlus Specialty Pharmacy (BioPlus), one ... 2016 Asembia Specialty Pharmacy Summit held May 2-6, 2016 at the Wynn & ... conference for the specialty pharmacy industry, with thousands of pharmacy providers, pharma/biotech manufacturers, ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... LAKE OSWEGO, Ore. , May 3, 2016 /PRNewswire/ ... about the importance of extending care beyond the implant ... Scientific Sessions, May 4-7 in San Francisco ... tasked with continually delivering the highest quality of patient ... ensuring patients are cared for each and every tomorrow," ...
(Date:5/3/2016)...  Specialty Silicone Fabricators is offering teachers a ... cleanroom works. The free visual aid provides a ... Chris Mazelin , SSF ... enthusiastically supports the Science, Technology, Engineering and Math ... generation of innovators. We want to provide resources ...
(Date:5/3/2016)... , May 3, 2016 ... heute bekannt, dass sie einen entscheidenden Meilenstein ... haben: Ein Aufruf zum Handeln, um Patientenresultate ... Veröffentlichung trägt zu Fortschritten im Verständnis der ... hervor, ein Bewusstsein für Hepatische Enzephalopathie in ...
Breaking Medicine Technology: